1.
Elisabet E. Manasanch, Jatin J. Shah, Hans C. Lee, Donna M. Weber, Sheeba K. Thomas, Behrang Amini, Jasper Olsem, Brandon Crumpton, Ashley Morphey, Zuzana Berkova, Lei Feng, Robert Z. Orlowski. Phase I/Ib study of carfilzomib and panobinostat with or without dexamethasone in patients with relapsed/refractory multiple myeloma. haematol [Internet]. 2020May1 [cited 2021Mar.8];105(5):e242-e245. Available from: https://haematologica.org/article/view/9411